Assisted reproductive technology utilization for cancer survivors: how we can do better

This is the authors' abstract. We don't add key points for this paper.

With an increasing population of reproductive-aged cancer survivors, there is a growing need for fertility preservation services.1 Chen et al. highlights the more frequent utilization of assisted reproductive technology (ART) among cancer patients who ultimately conceive, underscoring the importance of access to timely and effective fertility preservation options.2 This article highlights the successful cases—those with cancer-associated infertility and subsequent live birth. But with large population-based studies come limitations. What is not captured are likely many other cases—those who did not have access to fertility preservation, those who pursued ART and did not have success, and those who were unable to achieve their desired family size. We can only extrapolate that the successful cases included in this study represent only a small proportion of a much larger patient population. Logic would dictate that those who had early oncofertility referrals and access to care were more likely to succeed. Regardless, this study clearly demonstrates that cancer survivors require ART for family building.